TGF-β signaling and the fibrotic response
The DOI matches its Crossref record; 152 of the 153 references it cites were found in a registry or an index.
Abstract
The cause of fibrotic diseases, pathologies characterized by excessive production, deposition, and contraction of extracellular matrix, is unknown. To understand the molecular basis of fibrotic disease, it is essential to appreciate how matrix deposition is normally controlled and how this process is dysregulated in fibrogenesis. This review discusses the current state of knowledge concerning interactions among the profibrotic proteins transforming growth factor‐β (TGF‐β), connective tissue growth factor (CTGF, CCN2), and ED‐A fibronectin (ED‐A FN) and the antifibrotic proteins tumor necrosis factor‐α (TNF‐α) and γ‐interferon (IFN‐γ).—Leask, A., Abraham, D. J. TGF‐β signaling and the fibrotic response. FASEB J. 18, 816–827 (2004)
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“TGF-β is the critical mediator of pathological fibrosis after myocardial injury [64].”
From Cardiovascular disease models: A game changing paradigm in drug discovery and screening (2019) · cites this paper as [64]
In the citing paper
“TNFα also suppresses the TGFβ stimulation of ECM production.62”
From The Innate Immune System in Acute and Chronic Wounds (2016) · cites this paper as [62]
Citations
Cites
1 retracted
RETRACTED: Deficient Smad7 expression: A putative molecular defect in scleroderma
Dong, C., Zhu, S., Wang, T., Yoon, W., Li, Z., Alvarez, R. J., ten Dijke, P., White, B., Wigley, F. M., & Goldschmidt-Clermont, P. J. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.062010399 · Cited by 244 · cited 1×
“Although one report showed decreased levels of the inhibitory Smad7 in scleroderma fibroblasts (94), two other studies showed no difference in Smad7 levels between normal and scleroderma fibroblasts (65, 91); thus, Smad7 deficiency does not seem to be a general feature of scleroderma fibroblasts.”
ResultRetractedMassagué, J. (1998) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.67.1.753 · Cited by 7,556 · cited 4×
“The TGF- superfamily includes nearly 30 proteins in mammals including TGF- s, activins and inhibins, nodal, myostatin, bone morphogenetic proteins (BMPs), growth/differentiation factors (GDFs), and anti-Müllerian hormone (AMH, also called Müllerianinhibiting substance or MIS) (15, 16).”
BackgroundInfluentialDarnell, J. E., Kerr, L. M., & Stark, G. R. (1994) · Science · doi:10.1126/science.8197455 · Cited by 6,080 · cited 2×
“Transcriptional responses induced by IFN- in most cells are mediated through the Jak-Stat pathway (146).”
BackgroundCELLULAR RESPONSES TO INTERFERON-γ
Boehm, U., Klamp, T., Groot, M., & Howard, J. C. (1997) · Annual Review of Immunology · doi:10.1146/annurev.immunol.15.1.749 · Cited by 2,890 · cited 1×
“IFN- , a pleiotropic cytokine produced by T cells and NK cells, plays fundamental roles in innate and acquired immune responses (145).”
BackgroundYu, Q., & Stamenkovic, I. (2000) · PubMed Central · Cited by 2,203
Munger, J. S., Huang, X., Kawakatsu, H., Griffiths, M. J. D., Dalton, S. L., Wu, J., Pittet, J.-F., Kaminski, N., Garat, C., Matthay, M. A., et al. (1999) · Cell · doi:10.1016/s0092-8674(00)80545-0 · Cited by 2,076 · cited 1×
“TSP-1 null mice demonstrate a partial phenotypic overlap with TGF- 1 null animals (30), and integrin 6 / are highly resistant to lung fibrosis induced by the profibrotic drug bleomycin (31).”
BackgroundIdentification of Smad7, a TGFβ-inducible antagonist of TGF-β signalling
Nakao, A., Afrakhte, M., Morn, A., Nakayama, T., Christian, J. L., Heuchel, R., Itoh, S., Kawabata, M., Heldin, N.-E., Heldin, C.-H., et al. (1997) · Nature · doi:10.1038/39369 · Cited by 1,809
Yu, Q., & Stamenkovic, I. (2000) · Genes & Development · doi:10.1101/gad.14.2.163 · Cited by 1,754 · cited 1×
“For example, the plasmin proteases MMP-2 and -9, which promote matrix degradation (24), activate TGF- (25, 26).”
BackgroundThe myofibroblast in wound healing and fibrocontractive diseases
Gabbiani, G. (2003) · The Journal of Pathology · doi:10.1002/path.1427 · Cited by 1,630 · cited 5×
“observed in lesions of fibrotic disease (2).”
BackgroundInfluentialMaking sense of latent TGFβ activation
Annes, J. P., Munger, J. S., & Rifkin, D. B. (2003) · Journal of Cell Science · doi:10.1242/jcs.00229 · Cited by 1,628
Research works printed but not linked: 3
- 10.1111/j.1523-1755.2002.kid567.x · doi:10.1111/j.1523-1755.2002.kid567.x · Paper page
- Schmid P., 1998, Enhanced expression oftransforming growth factor-beta type and type II receptors in wound granulation tissue and hyper trophic scar, Am. J. Pathol., 152, 485
- 10.1111/j.1523-1755.1998.00820.x · doi:10.1111/j.1523-1755.1998.00820.x · Paper page
Cited by
Items 101–200 of 1,008
MiR-125b Is Critical for Fibroblast-to-Myofibroblast Transition and Cardiac Fibrosis
Nagpal, V., Rai, R., Place, A. T., Murphy, S. B., Verma, S. K., Ghosh, A. K., & Vaughan, D. E. (2016) · Circulation · doi:10.1161/circulationaha.115.018174 · Cited by 244
Redox-fibrosis: Impact of TGFβ1 on ROS generators, mediators and functional consequences
Richter, K., Konzack, A., Pihlajaniemi, T., Heljasvaara, R., & Kietzmann, T. (2015) · Redox Biology · doi:10.1016/j.redox.2015.08.015 · Cited by 238
Chronic hepatitis C and liver fibrosis
Sebastiani, G. (2014) · World Journal of Gastroenterology · doi:10.3748/wjg.v20.i32.11033 · Cited by 233
Transforming Growth Factor-β: Master Regulator of the Respiratory System in Health and Disease
Aschner, Y., & Downey, G. P. (2016) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2015-0391tr · Cited by 237
The IL-4/IL-13 axis in skin fibrosis and scarring: mechanistic concepts and therapeutic targets
Nguyen, J. K., Austin, E., Huang, A., Mamalis, A., & Jagdeo, J. (2020) · Archives of Dermatological Research · doi:10.1007/s00403-019-01972-3 · Cited by 226
Quan, T., Shao, Y., He, T., Voorhees, J. J., & Fisher, G. J. (2010) · Journal of Investigative Dermatology · doi:10.1038/jid.2009.224 · Cited by 239
“CTGF was originally isolated from cultured endothelial cells and later reported to be highly expressed in fibrotic disorders (Bradham et al., 1991; Frazier et al., 1996; Grotendorst et al., 1996; Grotendorst, 1997; Abraham et al., 2000; Leask and Abraham, 2003, 2004).”
BackgroundAhluwalia, N., Shea, B. S., & Tager, A. M. (2014) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201403-0509pp · Cited by 235
Matrix metalloproteinase-9 activates TGF-β and stimulates fibroblast contraction of collagen gels
Kobayashi, T., Kim, H., Liu, X., Sugiura, H., Kohyama, T., Fang, Q., Wen, F.-Q., Abe, S., Wang, X., Atkinson, J. J., et al. (2014) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00015.2014 · Cited by 229
Bejerano, T., Etzion, S., Elyagon, S., Etzion, Y., & Cohen, S. (2018) · Nano Letters · doi:10.1021/acs.nanolett.8b02578 · Cited by 230
The Processes and Mechanisms of Cardiac and Pulmonary Fibrosis
Murtha, L. A., Schuliga, M. J., Mabotuwana, N. S., Hardy, S. A., Waters, D. W., Burgess, J. K., Knight, D. A., & Boyle, A. J. (2017) · Frontiers in Physiology · doi:10.3389/fphys.2017.00777 · Cited by 229
“The renin-angiotensin system is another well-established regulator of cardiac fibrosis (Leask and Abraham, 2004; Haudek et al., 2010; Frangogiannis, 2014; Kong et al., 2014).”
BackgroundOzone and Ozonated Oils in Skin Diseases: A Review
Travagli, V., Zanardi, I., Valacchi, G., & Bocci, V. (2010) · Mediators of Inflammation · doi:10.1155/2010/610418 · Cited by 220
“This interpretation is also bolstered by data on TGF-β a crucial modulator of tissue remodeling and is linked to both NFkB status as well as to levels of oxidative stress during entire wound healing process [40].”
MethodHan, H., Hou, Y., Chen, X., Zhang, P., Kang, M., Jin, Q., Ji, J., & Gao, M. (2020) · Journal of the American Chemical Society · doi:10.1021/jacs.0c00650 · Cited by 231
Stromagenesis: The changing face of fibroblastic microenvironments during tumor progression
Beacham, D. A., & Cukierman, E. (2005) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2005.05.003 · Cited by 225
Metabolic Reprogramming Is Required for Myofibroblast Contractility and Differentiation
Bernard, K., Logsdon, N. J., Ravi, S., Xie, N., Persons, B. P., Rangarajan, S., Zmijewski, J. W., Mitra, K., Liu, G., Darley-Usmar, V. M., et al. (2015) · Journal of Biological Chemistry · doi:10.1074/jbc.m115.646984 · Cited by 224
“Transforming growth factor -1 (TGF- 1) is the prototypical repair cytokine that induces the expression of cytoskeletal proteins such as -smooth muscle actin ( -SMA)(2) and extracellular matrix proteins that are critical for its contractile/synthetic functions (3); hence, -SMA expression is used as a marker of myofibro…”
BackgroundGene expression profiling of cutaneous wound healing
Deonarine, K., Panelli, M. C., Stashower, M. E., Jin, P., Smith, K., Slade, H. B., Norwood, C., Wang, E., Marincola, F. M., & Stroncek, D. F. (2007) · Journal of Translational Medicine · doi:10.1186/1479-5876-5-11 · Cited by 229
“Connective tissue growth factor (CTGF) or CCN2 [33,34] is an important wound healing growth factor that promotes fibrosis.”
Cardiovascular disease models: A game changing paradigm in drug discovery and screening
Savoji, H., Mohammadi, M. H., Rafatian, N., Toroghi, M. K., Wang, E. Y., Zhao, Y., Korolj, A., Ahadian, S., & Radisic, M. (2019) · Biomaterials · doi:10.1016/j.biomaterials.2018.09.036 · Cited by 223
Formation and Prevention of Postoperative Abdominal Adhesions
Boland, G. M., & Weigel, R. J. (2006) · Journal of Surgical Research · doi:10.1016/j.jss.2005.12.002 · Cited by 221
Ponticos, M., Holmes, A. M., Shi‐Wen, X., Leoni, P., Khan, K., Rajkumar, V. S., Hoyles, R. K., Bou‐Gharios, G., Black, C. M., Denton, C. P., et al. (2009) · Arthritis & Rheumatism · doi:10.1002/art.24620 · Cited by 220
Self-citationLi, P., Wang, D., Lucas, J., Oparil, S., Xing, D., Cao, X., Novak, L., Renfrow, M. B., & Chen, Y.-F. (2008) · Circulation Research · doi:10.1161/circresaha.107.157677 · Cited by 219
TGF-β1is a negative regulator of lymphatic regeneration during wound repair
Clavin, N. W., Avraham, T., Fernandez, J., Daluvoy, S. V., Soares, M. A., Chaudhry, A., & Mehrara, B. J. (2008) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00879.2008 · Cited by 215
Integrin-mediated regulation of TGFβ in fibrosis
Henderson, N. C., & Sheppard, D. (2013) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2012.10.005 · Cited by 210
Lai, J.-J., Lai, K.-P., Chuang, K.-H., Chang, P., Yu, I.-C., Lin, W.-J., & Chang, C. (2009) · Journal of Clinical Investigation · doi:10.1172/jci39335 · Cited by 212
Endogenous interferon-γ is required for efficient skeletal muscle regeneration
Cheng, M., Nguyen, M.-H., Fantuzzi, G., & Koh, T. J. (2008) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00568.2007 · Cited by 214
Posterior capsule opacification: What's in the bag?
Wormstone, I. M., Wormstone, Y. M., Smith, A. J. O., & Eldred, J. A. (2021) · Progress in Retinal and Eye Research · doi:10.1016/j.preteyeres.2020.100905 · Cited by 203
Di Sabatino, A., Jackson, C. L., Pickard, K. M., Buckley, M., Rovedatti, L., Leakey, N. A. B., Picariello, L., Cazzola, P., Monteleone, G., Tonelli, F., et al. (2009) · Gut · doi:10.1136/gut.2008.149096 · Cited by 209
Mechanotransduction and fibrosis
Duscher, D., Maan, Z. N., Wong, V. W., Rennert, R. C., Januszyk, M., Rodrigues, M., Hu, M., Whitmore, A. J., Whittam, A. J., Longaker, M. T., et al. (2014) · Journal of Biomechanics · doi:10.1016/j.jbiomech.2014.03.031 · Cited by 200
“(Leask and Abraham, 2004; LeBleu et al., 2013) Another major target of focal adhesion components and FAK signaling is the Rho family of GTPases.”
BackgroundSonnylal, S., Denton, C. P., Zheng, B., Keene, D. R., He, R., Adams, H. P., VanPelt, C. S., Geng, Y. J., Deng, J. M., Behringer, R. R., et al. (2007) · Arthritis & Rheumatism · doi:10.1002/art.22328 · Cited by 198
Sundaresan, N. R., Bindu, S., Pillai, V. B., Samant, S., Pan, Y., Huang, J.-Y., Gupta, M., Nagalingam, R. S., Wolfgeher, D., Verdin, E., et al. (2016) · Molecular and Cellular Biology · doi:10.1128/mcb.00586-15 · Cited by 205
Togo, S., Holz, O., Liu, X., Sugiura, H., Kamio, K., Wang, X., Kawasaki, S., Ahn, Y., Fredriksson, K., Skold, C. M., et al. (2008) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200706-929oc · Cited by 202
Fichtner-Feigl, S., Fuss, I. J., Young, C. A., Watanabe, T., Geissler, E. K., Schlitt, H.-J., Kitani, A., & Strober, W. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.178.9.5859 · Cited by 199
TGF-β in fibrosis by acting as a conductor for contractile properties of myofibroblasts
Vallée, A., & Lecarpentier, Y. (2019) · Cell & Bioscience · doi:10.1186/s13578-019-0362-3 · Cited by 194
TGF-β2 is an exercise-induced adipokine that regulates glucose and fatty acid metabolism
Takahashi, H., Alves, C. R. R., Stanford, K. I., Middelbeek, R. J. W., Nigro, P., Ryan, R. E., Xue, R., Sakaguchi, M., Lynes, M. D., So, K., et al. (2019) · Nature Metabolism · doi:10.1038/s42255-018-0030-7 · Cited by 204
Etiopathology of chronic tubular, glomerular and renovascular nephropathies: Clinical implications
López-Novoa, J. M., Rodríguez-Peña, A. B., Ortiz, A., Martínez-Salgado, C., & López Hernández, F. J. (2011) · Journal of Translational Medicine · doi:10.1186/1479-5876-9-13 · Cited by 195
“Zeisberg M, Duffield JS: Resolved: EMT produces fibroblasts in the kidney.”
BackgroundInfluentialJohnson, L. A., Rodansky, E. S., Haak, A. J., Larsen, S. D., Neubig, R. R., & Higgins, P. D. R. (2014) · Inflammatory Bowel Diseases · doi:10.1097/01.mib.0000437615.98881.31 · Cited by 197
Zhang, Y., Bo, J., Taffet, G. E., Chang, J., Shi, J., Reddy, A. K., Michael, L. H., Schneider, M. D., Entman, M. L., Schwartz, R. J., et al. (2006) · The FASEB Journal · doi:10.1096/fj.05-5129com · Cited by 200
The Foreign Body Response Demystified
Chandorkar, Y., K, R., & Basu, B. (2019) · ACS Biomaterials Science & Engineering · doi:10.1021/acsbiomaterials.8b00252 · Cited by 201
Moon, J.-A., Kim, H.-T., Cho, I.-S., Sheen, Y. Y., & Kim, D.-K. (2006) · Kidney International · doi:10.1038/sj.ki.5001775 · Cited by 197
Phenotypic transitions and fibrosis in diabetic nephropathy
Simonson, M. S. (2007) · Kidney International · doi:10.1038/sj.ki.5002180 · Cited by 202
TGF-β and WNT signaling pathways in cardiac fibrosis: non-coding RNAs come into focus
Yousefi, F., Shabaninejad, Z., Vakili, S., Derakhshan, M., Movahedpour, A., Dabiri, H., Ghasemi, Y., Mahjoubin-Tehran, M., Nikoozadeh, A., Savardashtaki, A., et al. (2020) · Cell Communication and Signaling · doi:10.1186/s12964-020-00555-4 · Cited by 196
Clinical and Morphological Conditions in Capsular Contracture Formed around Silicone Breast Implants
Prantl, L., Schreml, S., Fichtner-Feigl, S., P??ppl, N., Eisenmann-Klein, M., Schwarze, H., & F??chtmeier, B. (2007) · Plastic and Reconstructive Surgery · doi:10.1097/01.prs.0000264398.85652.9a · Cited by 200
Signalling by Transforming Growth Factor Beta Isoforms in Wound Healing and Tissue Regeneration
Gilbert, R., Vickaryous, M., & Viloria-Petit, A. (2016) · Journal of Developmental Biology · doi:10.3390/jdb4020021 · Cited by 195
Tumor Microenvironment, a Paradigm in Hepatocellular Carcinoma Progression and Therapy
Tahmasebi Birgani, M., & Carloni, V. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18020405 · Cited by 193
“In this way, matrix deposition or recruitment of immune cells at the site of inflammation are two of several important actions of TGF-β cascade [30].”
BackgroundScleroderma pathogenesis: a pivotal role for fibroblasts as effector cells
Gilbane, A. J., Denton, C. P., & Holmes, A. M. (2013) · Arthritis Research & Therapy · doi:10.1186/ar4230 · Cited by 196
“Fibrosis, like wound healing, is instigated by fi broblast activation, proliferation and migration of these cells into the site of trauma and deposition of matrix proteins such as fi bronectin and collagen [8].”
BackgroundCurcumin and Liver Disease: from Chemistry to Medicine
Nabavi, S. F., Daglia, M., Moghaddam, A. H., Habtemariam, S., & Nabavi, S. M. (2014) · Comprehensive Reviews in Food Science and Food Safety · doi:10.1111/1541-4337.12047 · Cited by 192
Alexandre, N., Ribeiro, J., Gärtner, A., Pereira, T., Amorim, I., Fragoso, J., Lopes, A., Fernandes, J., Costa, E., Santos-Silva, A., et al. (2014) · Journal of Biomedical Materials Research Part A · doi:10.1002/jbm.a.35098 · Cited by 187
Extracellular Matrix Proteins in Hemostasis and Thrombosis
Bergmeier, W., & Hynes, R. O. (2012) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a005132 · Cited by 182
“As one example, fibronectin levels and inclusion of the alternatively spliced segments, EIIIA and EIIIB, increase in atherosclerotic plaques, in vessel walls after myocardial infarction, and in cancer (Astrof and Hynes, 2009), and mice engineered to express EIIIAþ fibronectin in their plasma, in which it is normally a…”
BackgroundMendias, C. L., Gumucio, J. P., Davis, M. E., Bromley, C. W., Davis, C. S., & Brooks, S. V. (2012) · Muscle & Nerve · doi:10.1002/mus.22232 · Cited by 188
Human airway organoid engineering as a step toward lung regeneration and disease modeling
Tan, Q., Choi, K. M., Sicard, D., & Tschumperlin, D. J. (2017) · Biomaterials · doi:10.1016/j.biomaterials.2016.10.046 · Cited by 191
Kang, H.-R., Cho, S. J., Lee, C. G., Homer, R. J., & Elias, J. A. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m610764200 · Cited by 186
Guha, M., Xu, Z., Tung, D., Lanting, L., & Natarajan, R. (2007) · The FASEB Journal · doi:10.1096/fj.06-6713com · Cited by 187
Poulsen, S. S., Saber, A. T., Williams, A., Andersen, O., Købler, C., Atluri, R., Pozzebon, M. E., Mucelli, S. P., Simion, M., Rickerby, D., et al. (2015) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2014.12.011 · Cited by 185
“…fi broblast-to-myo fi broblast conversion and epithelial – mesenchymal transition (EMT), both resulting in increased levels of myo fi broblasts and subsequently increased collagen deposition (Wang et al., 2014; Willis and Borok, 2007; Willis et al., 2005; Kasai et al., 2005; Leask and Abraham, 2004).”
BackgroundLosartan ameliorates dystrophic epidermolysis bullosa and uncovers new disease mechanisms
Nyström, A., Thriene, K., Mittapalli, V., Kern, J. S., Kiritsi, D., Dengjel, J., & Bruckner‐Tuderman, L. (2015) · EMBO Molecular Medicine · doi:10.15252/emmm.201505061 · Cited by 180
“Recessive dystrophic epidermolysis bullosa with its obvious scarring phenotype can be viewed as a fibrotic disorder in which changes in TGF-b activity greatly contribute to disease progression (Leask & Abraham, 2004; Fine et al, 2009).”
BackgroundSandbo, N., & Dulin, N. (2011) · Translational Research · doi:10.1016/j.trsl.2011.05.004 · Cited by 179
Fibrocytes from burn patients regulate the activities of fibroblasts
Wang, J. F., Jiao, H., Stewart, T. L., Shankowsky, H. A., Scott, P. G., & Tredget, E. E. (2007) · Wound Repair and Regeneration · doi:10.1111/j.1524-475x.2006.00192.x · Cited by 182
Bernard, K., Logsdon, N. J., Benavides, G. A., Sanders, Y., Zhang, J., Darley-Usmar, V. M., & Thannickal, V. J. (2018) · Journal of Biological Chemistry · doi:10.1074/jbc.ra117.000444 · Cited by 174
Induction of cardiac fibroblast lysyl oxidase by TGF-β1 requires PI3K/Akt, Smad3, and MAPK signaling
Voloshenyuk, T. G., Landesman, E. S., Khoutorova, E., Hart, A. D., & Gardner, J. D. (2011) · Cytokine · doi:10.1016/j.cyto.2011.03.024 · Cited by 177
Principles of Cell Circuits for Tissue Repair and Fibrosis
Adler, M., Mayo, A., Zhou, X., Franklin, R. A., Meizlish, M. L., Medzhitov, R., Kallenberger, S. M., & Alon, U. (2020) · iScience · doi:10.1016/j.isci.2020.100841 · Cited by 177
Progressive pulmonary fibrosis is mediated by TGF-β isoform 1 but not TGF-β3
Ask, K., Bonniaud, P., Maass, K., Eickelberg, O., Margetts, P. J., Warburton, D., Groffen, J., Gauldie, J., & Kolb, M. (2008) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2007.08.016 · Cited by 172
“It may be difficult to imagine why TGF-β1 and -β3 exhibit such distinct features in vivo, considering that both are supposed to similarly bind to the type II TGF-β receptor and transduce signals to various intracellular pathways (Eickelberg, 2001; Leask & Abraham, 2004).”
BackgroundSemaphorin 7A plays a critical role in TGF-β1–induced pulmonary fibrosis
Kang, H.-R., Lee, C. G., Homer, R. J., & Elias, J. A. (2007) · The Journal of Experimental Medicine · doi:10.1084/jem.20061273 · Cited by 176
Guan, R., Yuan, L., Li, J., Wang, J., Li, Z., Cai, Z., Guo, H., Fang, Y., Lin, R., Liu, W., et al. (2022) · European Respiratory Journal · doi:10.1183/13993003.02307-2021 · Cited by 167
“During this process, transforming growth factor (TGF)- β 1, considered as the principal profibrotic cytokine, plays a key role in the persistent fibroblast activation and myofibroblast differentiation in fibrotic diseases [9].”
BackgroundSong, J., He, G.-N., & Dai, L. (2023) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2023.114705 · Cited by 162
Spiera, R. F., Gordon, J. K., Mersten, J. N., Magro, C. M., Mehta, M., Wildman, H. F., Kloiber, S., Kirou, K. A., Lyman, S., & Crow, M. K. (2011) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2010.143974 · Cited by 173
Limiting angiogenesis to modulate scar formation
Korntner, S., Lehner, C., Gehwolf, R., Wagner, A., Grütz, M., Kunkel, N., Tempfer, H., & Traweger, A. (2019) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2018.02.010 · Cited by 172
Delacroix, L., Moutier, E., Altobelli, G., Legras, S., Poch, O., Choukrallah, M.-A., Bertin, I., Jost, B., & Davidson, I. (2010) · Molecular and Cellular Biology · doi:10.1128/mcb.00756-09 · Cited by 159
TGF-β Signaling in Breast Cancer Cell Invasion and Bone Metastasis
Drabsch, Y., & ten Dijke, P. (2011) · Journal of Mammary Gland Biology and Neoplasia · doi:10.1007/s10911-011-9217-1 · Cited by 168
“Metastasis is the result of several sequential steps and represents a highly organized, non-random and organselective process [83] that involves interactions from a variety of proteolytic enzymes, growth factors, and cell-cell and cell-substrate adhesion molecules [84].”
BackgroundCCN2 (Connective Tissue Growth Factor) Promotes Fibroblast Adhesion to Fibronectin
Chen, Y., Abraham, D. J., Shi-wen, X., Pearson, J. D., Black, C. M., Lyons, K. M., & Leask, A. (2004) · Molecular Biology of the Cell · doi:10.1091/mbc.e04-06-0490 · Cited by 167
“Because CCN2 has profibrotic activity in vivo (Mori et al., 1999), CCN2 has been proposed to be a key mediator of the profibrotic effects of TGF (Grotendorst, 1997; Mori et al., 1999; Leask et al., 2004; Leask and Abraham, 2004).”
BackgroundSelf-citationHeindryckx, F., Binet, F., Ponticos, M., Rombouts, K., Lau, J., Kreuger, J., & Gerwins, P. (2016) · EMBO Molecular Medicine · doi:10.15252/emmm.201505925 · Cited by 168
“TGF b is considered a key factor that coordinates the interplay between parenchymal cells, inflammatory cells, and myofibroblasts (Leask & Abraham, 2004).”
Pan, X., Chen, Z., Huang, R., Yao, Y., & Ma, G. (2013) · PLoS ONE · doi:10.1371/journal.pone.0060335 · Cited by 164
“Studies have described the basics of TGF-b signaling and its relationship to tissue repair as well as fibrosis [5,27,28].”
BackgroundVascular fibrosis in atherosclerosis
Lan, T.-H., Huang, X.-Q., & Tan, H.-M. (2013) · Cardiovascular Pathology · doi:10.1016/j.carpath.2013.01.003 · Cited by 164
“Believed as the most important ECM regulator [93], TGF-beta plays a critical role in ECM accumulation and vascular remodeling via up-regulating the production of several agents, including growth factors (CTGF, FGF), related gene (c-myc, cjun, junBJI, p53) and PAI-1 [94–97].”
BackgroundShi‐wen, X., Kennedy, L., Renzoni, E. A., Bou‐Gharios, G., du Bois, R. M., Black, C. M., Denton, C. P., Abraham, D. J., & Leask, A. (2007) · Arthritis & Rheumatism · doi:10.1002/art.23134 · Cited by 163
Self-citationCencetti, F., Bernacchioni, C., Nincheri, P., Donati, C., & Bruni, P. (2010) · Molecular Biology of the Cell · doi:10.1091/mbc.e09-09-0812 · Cited by 159
“The antidifferentiating property of TGF 1 is well established (Olson et al., 1986; Leask and Abraham, 2004).”
Gold Nanoparticle Reprograms Pancreatic Tumor Microenvironment and Inhibits Tumor Growth
Saha, S., Xiong, X., Chakraborty, P. K., Shameer, K., Arvizo, R. R., Kudgus, R. A., Dwivedi, S. K. D., Hossen, M. N., Gillies, E. M., Robertson, J. D., et al. (2016) · ACS Nano · doi:10.1021/acsnano.6b02231 · Cited by 163
Connective tissue growth factor and cardiac fibrosis
Daniels, A., Van Bilsen, M., Goldschmeding, R., Van Der Vusse, G. J., & Van Nieuwenhoven, F. A. (2009) · Acta Physiologica · doi:10.1111/j.1748-1716.2008.01936.x · Cited by 161
“Although CTGF can be induced independent of TGFb activation, TGF-b remains a potent inducer of CTGF through the smad-signalling pathways in cardiac cells (Leask & Abraham 2004, Leask 2007).”
BackgroundIntegrins and integrin-related proteins in cardiac fibrosis
Chen, C., Li, R., Ross, R. S., & Manso, A. M. (2016) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2015.11.010 · Cited by 162
New developments in fibroblast and myofibroblast biology: Implications for fibrosis and scleroderma
Abraham, D. J., Eckes, B., Rajkumar, V., & Krieg, T. (2007) · Current Rheumatology Reports · doi:10.1007/s11926-007-0008-z · Cited by 166
Self-citationBlocking follistatin-like 1 attenuates bleomycin-induced pulmonary fibrosis in mice
Dong, Y., Geng, Y., Li, L., Li, X., Yan, X., Fang, Y., Li, X., Dong, S., Liu, X., Li, X., et al. (2015) · Journal of Experimental Medicine · doi:10.1084/jem.20121878 · Cited by 157
“They regulate both epithelial cell injury and fibroblast proliferation and transdifferentiation into myofibroblasts at the injury site (Leask and Abraham, 2004; Selman et al., 2008; Goodwin and Jenkins, 2009).”
Mohan, H., Krumbholz, M., Sharma, R., Eisele, S., Junker, A., Sixt, M., Newcombe, J., Wekerle, H., Hohlfeld, R., Lassmann, H., et al. (2010) · Brain Pathology · doi:10.1111/j.1750-3639.2010.00399.x · Cited by 161
MicroRNA-326 Regulates Profibrotic Functions of Transforming Growth Factor-β in Pulmonary Fibrosis
Das, S., Kumar, M., Negi, V., Pattnaik, B., Prakash, Y. S., Agrawal, A., & Ghosh, B. (2014) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2013-0195oc · Cited by 162
The cyclic AMP effector Epac integrates pro- and anti-fibrotic signals
Yokoyama, U., Patel, H. H., Lai, N. C., Aroonsakool, N., Roth, D. M., & Insel, P. A. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0801490105 · Cited by 159
Fibrogenesis of Parenchymal Organs
Kisseleva, T., & Brenner, D. A. (2008) · Proceedings of the American Thoracic Society · doi:10.1513/pats.200711-168dr · Cited by 161
Currently known risk factors for hypertrophic skin scarring: A review
Butzelaar, L., Ulrich, M. M. W., van der Molen, A. B. M., Niessen, F. B., & Beelen, R. H. J. (2015) · Journal of Plastic Reconstructive & Aesthetic Surgery · doi:10.1016/j.bjps.2015.11.015 · Cited by 171
Shi-Wen, X., Rodríguez-Pascual, F., Lamas, S., Holmes, A., Howat, S., Pearson, J. D., Dashwood, M. R., du Bois, R. M., Denton, C. P., Black, C. M., et al. (2006) · Molecular and Cellular Biology · doi:10.1128/mcb.00625-06 · Cited by 156
Self-citationFichtner–Feigl, S., Young, C. A., Kitani, A., Geissler, E. K., Schlitt, H., & Strober, W. (2008) · Gastroenterology · doi:10.1053/j.gastro.2008.08.055 · Cited by 158
Microenvironment of the Involuting Mammary Gland Mediates Mammary Cancer Progression
Schedin, P. S., O’Brien, J., Rudolph, M. C., Stein, T., & Borges, V. F. (2007) · Journal of Mammary Gland Biology and Neoplasia · doi:10.1007/s10911-007-9039-3 · Cited by 176
“025 YES [66–69]”
BackgroundAvraham, T., Yan, A., Zampell, J. C., Daluvoy, S. V., Haimovitz-Friedman, A., Cordeiro, A. P., & Mehrara, B. J. (2010) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00535.2009 · Cited by 154
EW-7197 inhibits hepatic, renal, and pulmonary fibrosis by blocking TGF-β/Smad and ROS signaling
Park, S.-A., Kim, M.-J., Park, S.-Y., Kim, J.-S., Lee, S., Woo, H. A., Kim, D.-K., Nam, J., & Sheen, Y. Y. (2014) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-014-1798-6 · Cited by 164
TGF-β–induced epigenetic deregulation of SOCS3 facilitates STAT3 signaling to promote fibrosis
Dees, C., Pötter, S., Zhang, Y., Bergmann, C., Zhou, X., Luber, M., Wohlfahrt, T., Karouzakis, E., Ramming, A., Gelse, K., et al. (2020) · Journal of Clinical Investigation · doi:10.1172/jci122462 · Cited by 171
Fibrosis and immune dysregulation in systemic sclerosis
Chizzolini, C., Brembilla, N. C., Montanari, E., & Truchetet, M. (2010) · Autoimmunity Reviews · doi:10.1016/j.autrev.2010.09.016 · Cited by 165
“matricellular proteins [26,27].”
TLR4 Promotes Fibrosis but Attenuates Tubular Damage in Progressive Renal Injury
Pulskens, W. P., Rampanelli, E., Teske, G. J., Butter, L. M., Claessen, N., Luirink, I. K., van der Poll, T., Florquin, S., & Leemans, J. C. (2010) · Journal of the American Society of Nephrology · doi:10.1681/asn.2009070722 · Cited by 155
Tang, B., Zhu, B., Liang, Y., Bi, L., Hu, Z., Chen, B., Zhang, K., & Zhu, J. (2011) · Archives of Dermatological Research · doi:10.1007/s00403-010-1114-8 · Cited by 174
“TGF-b, especially TGF-b1, plays an important role in wound healing and scar formation [13, 19].”
BackgroundInfluentialThe Epithelial-to-Mesenchymal Transition as a Possible Therapeutic Target in Fibrotic Disorders
Di Gregorio, J., Robuffo, I., Spalletta, S., Giambuzzi, G., De Iuliis, V., Toniato, E., Martinotti, S., Conti, P., & Flati, V. (2020) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2020.607483 · Cited by 145
“TGF-β and the Canonical Signaling Transforming growth factor-beta is the main growth factor involved in fibrosis (Leask and Abraham, 2004) (Figure 2).”
BackgroundInfluentialMechanisms of Oncostatin M-Induced Pulmonary Inflammation and Fibrosis
Mozaffarian, A., Brewer, A. W., Trueblood, E. S., Luzina, I. G., Todd, N. W., Atamas, S. P., & Arnett, H. A. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.181.10.7243 · Cited by 153
“plicated in the cleaving and subsequent activation of a number of proteins, including TGF- , a potent profibrotic cytokine (16).”
BackgroundLe Bihan, M.-C., Bigot, A., Jensen, S. S., Dennis, J. L., Rogowska-Wrzesinska, A., Lainé, J., Gache, V., Furling, D., Jensen, O. N., Voit, T., et al. (2012) · Journal of Proteomics · doi:10.1016/j.jprot.2012.09.008 · Cited by 153
“Examples include VEGF-C and Placenta growth factor (PGF) which act on blood vessels [43], GDF15 on inflammatory cells [44], and CTGF on neighboring fibroblasts [45].”
BackgroundRole of Transforming Growth Factor-β in Skeletal Muscle Fibrosis: A Review
Ismaeel, A., Kim, J., Kirk, J. S., SMITH, R. S., Bohannon, W. T., & Koutakis, P. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20102446 · Cited by 170
“TGF-β functions to promote extracellular matrix (ECM) preservation by enhancing matrix protein synthesis, promoting expression of ECM and profibrotic genes such as type I collagen and connective tissue growth factor (CTGF), and suppressing the activity of ECM degradation proteins such as matrix metalloproteinases (MMP…”
BackgroundTransforming Growth Factor: β Signaling Is Essential for Limb Regeneration in Axolotls
Lévesque, M., Gatien, S., Finnson, K., Desmeules, S., Villiard, É., Pilote, M., Philip, A., & Roy, S. (2007) · PLoS ONE · doi:10.1371/journal.pone.0001227 · Cited by 149
“TGF-b1 is the most studied member of this family for its roles in wound healing processes and immune response in mammals [24–28].”
BackgroundReducing CTGF/CCN2 slows down mdx muscle dystrophy and improves cell therapy
Morales, M. G., Gutierrez, J., Cabello-Verrugio, C., Cabrera, D., Lipson, K. E., Goldschmeding, R., & Brandan, E. (2013) · Human Molecular Genetics · doi:10.1093/hmg/ddt352 · Cited by 145
αv integrins: key regulators of tissue fibrosis
Conroy, K. P., Kitto, L. J., & Henderson, N. C. (2016) · Cell and Tissue Research · doi:10.1007/s00441-016-2407-9 · Cited by 147
“Secreted transforming growth factor beta (TGFβ) is a key regulator of fibrosis in multiple organs (Ignotz and Massagué 1986; Roberts et al. 1986; Hynes 2002; Leask and Abraham 2004).”
German guidelines for the diagnosis and therapy of localized scleroderma
Kreuter, A., Krieg, T. M., Worm, M., Wenzel, J., Moinzadeh, P., Kuhn, A., Aberer, E., Scharffetter‐Kochanek, K., Horneff, G., Reil, E., et al. (2016) · JDDG Journal der Deutschen Dermatologischen Gesellschaft · doi:10.1111/ddg.12724 · Cited by 152
TGF-beta 1 induced fibroblast proliferation is mediated by the FGF-2/ERK pathway
Xiao, L. (2012) · Frontiers in Bioscience · doi:10.2741/4077 · Cited by 148
Estrogen status and skeletal muscle recovery from disuse atrophy
McClung, J. M., Davis, J. M., Wilson, M. A., Goldsmith, E. C., & Carson, J. A. (2006) · Journal of Applied Physiology · doi:10.1152/japplphysiol.01583.2005 · Cited by 147
“Additionally, the transforming growth factor- (TGF- ) signaling pathway appears to be critical for regulation of extracellular matrix remodeling (38).”
Background
Metadata
- Authors
- Leask, A., & Abraham, D. J.
- Affiliations
- The Royal Free Hospital (GB)
- Venue
- The FASEB Journal
- Publisher
- Wiley
- Published
- 2004-05
- Volume
- 18
- Issue
- 7
- Pages
- 816-827
- ISSN
- 0892-6638 (ISSN-L)
- 1530-6860
- OpenAlex
- W2122808924
- Cited by
- 2,319
- References
- 153
- Citations by year
- 2026: 53 · 2025: 53 · 2024: 63 · 2023: 79 · 2022: 75 · 2021: 103 · 2020: 99 · 2019: 113 · 2018: 145 · 2017: 174 · 2016: 163 · 2015: 179 · 2014: 141 · 2013: 134 · 2012: 115
- FWCI
- 6.39
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- The FASEB Journal (publishedVersion)
- PubMed (publishedVersion)
- UCL Discovery (University College London) (submittedVersion)
- Funders
- Scleroderma Foundation
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Connective Tissue Growth Factor Research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › TGF-β signaling in diseases
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiac Fibrosis and Remodeling
- Keywords
- TGF-beta signaling, fibrosis, fibrogenesis, extracellular matrix deposition, connective tissue growth factor, ED-A fibronectin, TNF-α, interferon-gamma
- MeSH terms
- Animals, DNA-Binding Proteins, Fibronectins, Fibrosis, Gene Expression Regulation, Humans, Interferon-gamma, Tumor Necrosis Factor-alpha, Wound Healing, Signal Transduction, Trans-Activators, Transforming Growth Factor beta, Extracellular Matrix Proteins, Immediate-Early Proteins, Receptors, Transforming Growth Factor beta, MAP Kinase Signaling System, Intercellular Signaling Peptides and Proteins, Smad3 Protein, Smad4 Protein, Connective Tissue Growth Factor
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.